What Laboratorios Raymos does

Laboratorios Raymos is an Argentine pharmaceutical manufacturer founded in 1960 and headquartered in Buenos Aires. The company produces a range of pharmaceutical products spanning its branded lines including RAYMOS+CERC and Flexresan, and has extended its offering into a digital drug reference application called Vademecum. The firm operates as a private, for-profit enterprise with an employee base of 251-500 people, suggesting a mid-sized manufacturer serving the domestic Argentine healthcare market through traditional wholesale, pharmacy, and potentially institutional channels.

The company's business model is anchored in physical pharmaceutical manufacturing and sales within Argentina, with the Vademecum app representing a digital adjacency that likely serves both as a prescriber/consumer drug reference tool and a brand-engagement asset. No pricing model, GTM motion, or revenue mechanics were disclosed in the source material, and the company's website displayed a verification/loading state that prevented deeper product or customer data extraction. There is no public information on revenue, funding history, ownership structure, or named customer accounts.

Operationally, Laboratorios Raymos sits within Argentina's regulated pharmaceutical sector under ANMAT oversight, which imposes GMP, product registration, and pharmacovigilance requirements that shape its cost structure and go-to-market approach. The firm has no disclosed subsidiaries, no recorded M&A activity, no publicly known partnerships, and no documented international expansion footprint. For diligence purposes, the available data confirms a long-standing, domestically focused pharma manufacturer of mid-scale, but leaves fundamental questions on revenue trajectory, customer mix, ownership, and growth strategy unaddressed by public sources.

Name

Laboratorios Raymos

Website

https://raymos.com

Company type

Private

Founded year

1960

Headcount range

251–500 employees

Short description

Laboratorios Raymos is an Argentine pharmaceutical manufacturer founded in 1960 in Buenos Aires, producing branded products including RAYMOS+CERC and Flexresan, along with a Vademecum drug reference app, serving the domestic healthcare market.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

Keywords

• Pharmaceutical manufacturing
• Drug manufacturing
• Consumer pharmaceuticals
• Prescription medicines
• Healthcare applications

Headquarters

HQ city

Buenos Aires

HQ country

Argentina

HQ region

Latin America

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Core offering

Laboratorios Raymos is an Argentine pharmaceutical manufacturer that produces and sells a portfolio of branded pharmaceutical products, including the RAYMOS+CERC and Flexresan lines. The company complements its manufacturing business with the Vademecum mobile application, a digital healthcare reference tool that supports consumers with medication and drug information lookup.

Differentiator

Problem solved

Functional benefit

Products and services

• RAYMOS+CERC Branded pharmaceutical product line within the Raymos portfolio, produced by Laboratorios Raymos for consumer use in Argentina.
• Flexresan Branded pharmaceutical product line within the Raymos portfolio, produced by Laboratorios Raymos for consumer use in Argentina.
• Vademecum application Mobile application offered by Laboratorios Raymos that provides drug/medication reference and healthcare information lookup for consumer end-users in Argentina.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights1 record

Direct peers

• Laboratorios Casasco: Mid-sized Argentine pharmaceutical laboratory focused on branded generics and specialty pharmaceuticals. Comparable to Raymos by therapeutic coverage, Argentine market position, and historical scale.
• Laboratorios Richmond: Argentine pharmaceutical manufacturer with branded generics, specialty products, and biotechnology initiatives. Comparable to Raymos as a mid-sized Argentine pharma lab with multi-decade history and diversification.
• Laboratorios Bagó: One of the largest Argentine pharmaceutical manufacturers with a broad branded generics and specialty portfolio. Directly comparable to Laboratorios Raymos as a domestically rooted, multi-product pharma lab serving Argentina and Latin America.
• Laboratorios Roemmers: Leading Argentine pharmaceutical group with a diversified branded and generic portfolio plus consumer health lines. Closely comparable to Raymos by therapeutic breadth, Argentine origin, and Latin American commercial footprint.
• Baliarda: Argentine pharmaceutical laboratory with broad branded generics and specialty lines. Comparable to Raymos by Argentine origin, multi-decade history, and therapeutic diversification.
• Laboratorios Andrómaco: Chilean-Argentine pharmaceutical manufacturer with a presence across branded generics and OTC lines in South America. Comparable as a regional Latin American pharma lab with multi-product focus.
• Laboratorios Montpellier: Argentine pharmaceutical manufacturer with branded generics across multiple therapeutic categories. Comparable to Raymos by origin, product mix, and mid-market positioning in Argentina.
• Gador: Argentine pharmaceutical company with branded generics and specialty products sold across Latin America. Directly comparable as an Argentine-rooted, multi-product pharma manufacturer.
• Elea Pharmaceuticals: Argentine pharmaceutical company with branded generics and consumer health products. Comparable to Raymos by Argentine origin, multi-product strategy, and commercial scale across Latin America.

Broad incumbents

• Pfizer Argentina: Argentine subsidiary of a global pharmaceutical major offering branded specialty and biologics. Comparable as a competing Argentine pharma operator, but with vastly greater scale and capital resources than Raymos.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratorios Raymos